# Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study

> **NCT04332835** · PHASE2,PHASE3 · COMPLETED · sponsor: **Universidad del Rosario** · enrollment: 92 (actual)

## Conditions studied

- Coronavirus
- Coronavirus Infection

## Interventions

- **DRUG:** Plasma
- **DRUG:** Standard Therapy

## Key facts

- **NCT ID:** NCT04332835
- **Lead sponsor:** Universidad del Rosario
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-08
- **Primary completion:** 2020-10-31
- **Final completion:** 2020-11-15
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2020-11-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04332835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04332835, "Convalescent Plasma for Patients With COVID-19: A Randomized, Single Blinded, Parallel, Controlled Clinical Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04332835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*